Last SFr.283.20 CHF
Change Today -0.10 / -0.04%
Volume 2.4M
As of 11:43 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Severin Schwan Ph.D.

Chief Executive Officer and Director, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 46 board members in 5 different organizations across 12 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Severin Schwan, Ph.D serves as the Chief Executive Officer of F. Hoffmann-La Roche Ltd. Dr. Schwan serves as the Chief Executive Officer of Roche Diabetes Care AG. He has been the Group Chief Executive Officer of Roche Holding AG since March 2008. He serves as the Chief Executive Officer of Roche Group and Roche Holding Ltd. Dr. Schwan served as the Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006 and its Group Chief Executive Officer ...

Read Full Background

Corporate Headquarters*

Grenzacherstrasse 124
Basel, Basel-Stadt 4070


Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Director and Member of Scientific Resource Board
Former Director
Chief Executive Officer and Director
Director and Member of Risk Committee


Unknown/Other Education
University of Oxford
Unknown/Other Education 1991
Universität Innsbruck
LLB 1991
Universität Innsbruck
Unknown/Other Education
University of York
Doctorate 1993
Universite catholique de Louvain

Other Affiliations*

Annual Compensation*

Total Annual CompensationSFr.5,117,000

Stock Options*

Restricted Stock AwardsSFr.6,219,000
All Other CompensationSFr.1,865,000
Total Value of OptionsSFr.29,497,597
Total Number of Options369,515

Total Compensation*

Total Annual Cash CompensationSFr.6,982,000
Total Short Term CompensationSFr.5,117,000
Other Long Term CompensationSFr.8,084,000
Total Calculated CompensationSFr.13,201,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.283.20 CHF -0.10


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at